Announcements Trials
Browse Landscape

Phase

Phase NA 216Phase 2 19Phase 3 10Phase 2/3 6Phase EARLY_PHASE1 4Phase 1 3Phase 4 2Phase 1/2 2

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Sexual Dysfunction, Physiological 1Polycystic Ovary Syndrome 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Inflammation 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × Exercise × Clear all
NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Changi General Hospital

Phase 4 Completed
70 enrolled
EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT00593294 2008-01-15

Oral Contraceptive and Cardiovascular Risk in PCOS

Federico II University

Phase 4 Completed
150 enrolled

Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡